PASSAGE BIO INC (PASG) Stock Analyst Earnings Estimates
NASDAQ:PASG - Nasdaq - US7027121000 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A 248.38% | N/A 119.04% | N/A 57.85% | N/A -47.70% | N/A -43.70% | |||||||
| EBITDA YoY % growth | -13.47M | -37.06M -175.13% | -112.1M -202.48% | -184.19M -64.31% | -134.71M 26.86% | -99.278M 26.30% | N/A 28.11% | N/A -4.90% | N/A -2.26% | N/A 27.37% | N/A 119.54% | N/A 458.92% | N/A 129.67% | N/A 34.02% | N/A | |
| EBIT YoY % growth | -13.47M | -37.19M -176.10% | -112.9M -203.58% | -185.73M -64.51% | -138.39M 25.49% | -102.999M 25.57% | N/A 30.46% | N/A 5.53% | N/A -16.21% | N/A 34.21% | N/A 111.37% | N/A 1,856.47% | N/A 103.69% | N/A -55.15% | N/A -79.24% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | -3.08 | -3.48 -12.99% | -2.50 28.16% | -1.86 25.60% | N/A 47.68% | N/A 31.03% | N/A -12.72% | N/A 91.24% | N/A 1,823.08% | N/A 139.73% | N/A 52.70% | N/A -77.80% | N/A |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.21 30.64% | -0.25 15.68% | -0.25 2.32% | -0.22 27.61% | -0.23 -8.33% |
| Revenue Q2Q % growth | |||||
| EBITDA Q2Q % growth | -18.172M -23.41% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -17.945M 2.72% | -15.948M 11.65% | -15.704M 7.30% | -15.463M 2.79% | -15.228M 15.14% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.31 36.73% | -0.23 | -0.08 | -32.14% |
| Q2 2024 Q2Q % growth | -0.26 40.91% | -0.32 | 0.06 | 17.77% |
| Q1 2024 Q2Q % growth | -0.30 52.38% | -0.36 | 0.06 | 17.73% |
| Q4 2023 Q2Q % growth | -0.30 38.78% | -0.41 | 0.11 | 26.80% |
| Q3 2023 Q2Q % growth | -0.49 | -0.47 | -0.02 | -5.31% |
| Q2 2023 Q2Q % growth | -0.44 39.73% | -0.49 | 0.05 | 9.81% |
| Q1 2023 Q2Q % growth | -0.63 20.25% | -0.51 | -0.12 | -24.71% |
| Q4 2022 Q2Q % growth | -0.49 48.42% | -0.53 | 0.04 | 8.11% |
| Q3 2022 Q2Q % growth | -0.49 43.68% | -0.81 | 0.32 | 39.26% |
| Q2 2022 Q2Q % growth | -0.73 18.89% | -0.84 | 0.11 | 13.41% |
| Q1 2022 Q2Q % growth | -0.79 -3.95% | -0.91 | 0.12 | 12.75% |
| Q4 2021 Q2Q % growth | -0.95 -11.76% | -0.90 | -0.05 | -5.09% |
| Q3 2021 Q2Q % growth | -0.87 -38.10% | -0.88 | 0.01 | 1.01% |
| Q2 2021 Q2Q % growth | -0.90 -50.00% | -0.77 | -0.13 | -16.58% |
| Q1 2021 Q2Q % growth | -0.76 24.00% | -0.76 | 0.00 | -0.15% |
| Q4 2020 Q2Q % growth | -0.85 | -0.72 | -0.13 | -18.59% |
| Q3 2020 Q2Q % growth | -0.63 | -0.78 | 0.15 | 18.73% |
| Q2 2020 Q2Q % growth | -0.60 | -0.58 | -0.02 | -3.20% |
| Q1 2020 Q2Q % growth | -1.00 | -0.46 | -0.54 | -119.49% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 3.4M | -3.4M | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 2.86% | 8.93% | 0% | -7.8% |
| Revenue | N/A | N/A | N/A | N/A |